The European Union (EU) has officially approved a significant regulatory decision to ban the import of edible animal products derived from animals treated with antimicrobial compounds, including Monensin, for growth promotion after September 2026. This regulatory decision is outlined in specific regulations, namely (EU) 2023/905, and involves changes to the export certificates as specified in (EU) 2024/399.
This prohibition applies to all animal products that could be used in the manufacturing of meat and dairy products sold within the EU. Notably, it includes products from third countries that may be used as ingredients in goods intended for export to the EU. The implications of this decision will be substantial for countries such as Brazil, Uruguay, Paraguay, Australia, and many others all around the world that currently utilize Monensin as a growth promoter.
We are pleased to share that, as confirmed by our scientific publication in Animals MDPI , Anavrin can be considered a hashtag#natural hashtag#alternative to hashtag#Monensin as a growth promoter. This conclusion is based on the results of in vivo trials conducted in Uruguay in collaboration with the Universidad de la República
Our research findings indicate:
“The addition of a blend of essential oils, tannins, and bioflavonoids (Anavrin) to finishing steers fed a total mixed ration resulted in performance outcomes comparable to those achieved with Monensin.”
This development represents an important step toward sustainable animal production practices and aligns with the EU’s commitment to improve food safety and animal welfare.